Form 4 for MNPR Monopar Therapeutics
Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-30 · accession 0001437749-23-027585 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-03 | 2023-09-30 | MNPR | KLAUSNER ARTHUR J | Dir | M - OptEx | — | +2,533 | 28.3K | +10% | — |
| D | 2023-10-03 | 2023-09-30 | MNPR | KLAUSNER ARTHUR J | Dir | M - OptEx | $0.00 | -2,533 | 2,533 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-30 | M | A | 2,533 | — | 28,330 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Derivative | Restricted Stock Units | 2023-09-30 | M | D | 2,533 | $0.00 | 2,533 | D | — · — to — | 2,533 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F3) On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |